X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/trovagene-announces-changing-of-company-name-to-cardiff-oncology-and-appointment-of-mark-erlander-phd-as-chief-executive-officer-301053690.html
https://www.prnewswire.com/news-releases/onvansertib-trial-in-kras-mutated-colorectal-cancer-demonstrates-consistent-tumor-regression-across-kras-mutation-subtypes-and-durable-response-301048164.html
https://www.prnewswire.com/news-releases/trovagene-announces-acceptance-of-phase-1b2-kras-mutated-metastatic-colorectal-cancer-mcrc-trial-abstract-for-presentation-at-the-2020-asco-annual-meeting-301033146.html
https://www.prnewswire.com/news-releases/trovagene-presents-phase-2-data-demonstrating-the-ability-of-onvansertib-to-overcome-zytiga-resistance-and-provide-clinical-benefit-for-mcrpc-patients-301004287.html
https://www.prnewswire.com/news-releases/trovagene-to-present-new-clinical-data-for-onvansertib-in-metastatic-kras-mutated-colorectal-cancer-at-asco-2020-gastrointestinal-cancers-symposium-300989830.html
https://www.prnewswire.com/news-releases/trovagene-announces-data-from-acute-myeloid-leukemia-aml-phase-1b2-trial-of-onvansertib-chosen-for-oral-presentation-at-ash-2019-annual-meeting-300952602.html
https://www.prnewswire.com/news-releases/trovagene-announces-5-0-million-private-placement-priced-at-the-market-300945673.html
Market Place
Share 
